The global market for stretch mark removal fractional lasers is projected to grow at a CAGR of 7.5% through 2030. As consumer awareness regarding non-invasive aesthetic procedures rises, the demand for CO2 and 1550nm Erbium glass technologies has shifted from specialized hospitals to medium-sized aesthetic clinics and medical spas.
Technological trends are leaning towards Modularized Designs and AI-integrated skin analysis. Modern fractional lasers now offer "Smart Scan" modes that adjust energy density based on skin impedance, minimizing downtime while maximizing collagen remodeling for striae distansae (stretch marks).
Global buyers in the USA, Europe, and the Middle East are increasingly prioritizing Medical CE and FDA cleared devices. There is a strong preference for manufacturers who offer localized after-sales support and comprehensive clinical training, bridging the gap between hardware purchase and clinical success.
Stretch marks (striae) represent a significant challenge in dermatology. As a leading China Fractional Laser Manufacturer, Wuxi Aesthe has spent two decades refining the interaction between light energy and dermal tissue. Fractional photothermolysis works by creating thousands of microscopic treatment zones (MTZs) in the skin, leaving the surrounding tissue intact to facilitate rapid healing.
CO2 vs. 1550nm Erbium Glass: Our research indicates that for older, white stretch marks (striae alba), the 10600nm CO2 laser provides deeper remodeling and skin tightening. Conversely, for newer, red marks (striae rubra) or for patients with darker skin types (Fitzpatrick IV-VI), our 1550nm Erbium Glass systems offer a non-ablative approach with significantly lower risks of post-inflammatory hyperpigmentation (PIH).
Clinical Expertise: Our devices are engineered with ultra-short pulse durations to ensure thermal damage is confined strictly to the target area, a hallmark of professional-grade medical equipment.
In North America and Europe, our lasers are integrated into high-end medical spas focusing on postpartum recovery programs. In Southeast Asia and Latin America, the focus is often on scar revision and pigmentation control. We provide localized parameter presets in our software to cater to these diverse demographic needs.
Wuxi Aesthe combines the cost-efficiency of Chinese manufacturing with international quality standards. By owning the entire supply chain—from R&D to final assembly—we offer OEM/ODM flexibility that European brands cannot match, allowing distributors to customize hardware aesthetics and software UI.
We understand that trust is the foundation of the medical industry. Our factory is ISO 13485 certified, and our key products carry Medical CE and FDA approvals. This ensures that every pulse delivered by an Aesthe laser is consistent, safe, and backed by clinical evidence.
Wuxi Aesthe Medical Technology Co., Ltd. is a global leader in the development and manufacturing of light-based medical and aesthetic lasers in China. Since its establishment in 2000, Wuxi Aesthe has revolutionized the medical aesthetics industry with over 100 cutting-edge, customized products designed for a variety of medical and cosmetic treatments. Headquartered in Wuxi, China, we offer both OEM and ODM services, which allows us to say with pride: "We deliver exceptional quality!"
Our products are distributed worldwide, with customers in regions spanning from Africa to Europe, North America, and throughout Asia. We specialize in offering complete sets of medical and beauty equipment, including Intense Pulsed Light (IPL), E-light (IPL+RF), DPL, 808nm Diode Laser, CO2 Fractional Laser, ND:YAG Laser, 1064nm Long Pulsed Laser, and slimming devices.
To be a trusted leader in the medical aesthetics industry, delivering transformative solutions globally.
To make medical and cosmetic solutions more effective, efficient, and accessible to people worldwide, helping them look and feel their best.
At Wuxi Aesthe, we don’t see ourselves as mere service providers but as long-term partners in beauty and well-being. We are dedicated to ensuring that the beauty treatments we provide stand the test of time.
As we look toward 2025 and beyond, the integration of Artificial Intelligence (AI) in aesthetic laser systems is no longer a luxury but a requirement. Global enterprises are seeking machines that can automatically calibrate pulse energy by analyzing the skin's melanin index and moisture levels. At Wuxi Aesthe, our R&D is currently focused on hybrid laser systems—combining 1550nm and 10600nm wavelengths in a single platform to treat stretch marks at multiple depths simultaneously.
Another emerging trend is the miniaturization of professional technology. While large hospital units remain the standard for high-power treatments, there is a massive surge in demand for portable fractional lasers from mobile clinics and smaller aesthetic studios in developing markets. Our portable 1550nm Erbium Fiber Laser is a direct response to this global procurement shift, offering clinical-grade results in a modular, compact chassis.
Finally, the "Post-Pandemic Beauty Boom" has led to an increased focus on body treatments. Stretch mark removal is no longer seen as a niche service but a core offering for any serious medical aesthetic clinic. By partnering with a China-based manufacturer like Wuxi Aesthe, global exporters can access these high-growth markets with reliable, certified, and technologically superior equipment.
Aesthe Medical
